Qiming Venture Partners

Qiming Venture Partners is a prominent venture capital firm based in Shanghai, China, with additional offices in Beijing, Suzhou, and Hong Kong. Founded in 2006, the firm specializes in investing in early to growth-stage companies across various sectors, including healthcare, information technology, consumer products, media, and clean technology. Qiming has established itself as a leading investment firm in China, managing multiple funds with over $1 billion in assets. The firm focuses on supporting innovative entrepreneurs and companies that demonstrate high growth potential, particularly in the technology and healthcare landscapes. Through its strategic investments, Qiming aims to foster the development of new business models and technologies, contributing to the dynamic entrepreneurial ecosystem in China.

Zhang Ao

Executive Director

Artavazd Arumov Ph.D

Principal

Ryan Baker

CFO

Cyrus Chan

Associate

Kan Chen

Partner

Liwen Chen

Associate

Nan Chen

Principal

David Chu

Partner

Phil DiGiacomo

Principal

Anna French

Managing Partner

Yuxin Fu

Associate

Jinda Gao

Principal

Kuantai Yeh

Partner

Robert Headley

Partner

Maykin Ho Ph.D

Venture Partner

William Hu

Managing Partner

Duane Kuang

Founding Managing Partner

Nisa Leung

Managing Partner

Lisa Li

Investor

Dingzheng Li

Vice President

Jing Liu

Associate

Chang Liu

Associate

Bin Liu

Associate

Biao Lu

Associate

Shuo Mao

Principal

Will Mcconnell

Principal

Mark McDade

Co-Founder and Managing Partner

Gary Rieschel

Founder and Managing Partner

Motao Sun

Associate

Amy Tang

Venture Partner

Yi Tang

Principal

Shiyu Wang

Partner

Shiyu Wang

Partner

Bonnie Wang

Principal

Rachel Wang

Venture Partner

Xin Wang

Investor

James Wang

Venture Partner

Gillian Xu

RMB funds CFO

Kuantai Yeh

Partner

Peter (Ming) Yin

Principal, Cleantech

Janet Yu Ph.D

Partner

Liang Yuyu

Managing Partner

Oscar Zhang

Principal

Yafeng Zhou

Associate

Alex Zhou

Managing Partner

Zhiyuan Zhou

Investor

Zhifeng Zhou

Managing Partner

Yiqing Zhu

Associate

Jing-Shan Hu Ph.D

Venture Partner of Healthcare

Phillip DiGiacomo Ph.D

Principal

Past deals in API

BlockVision

Seed Round in 2022
BlockVision operates as a high-availability indexing network that facilitates complex queries and data storage across various blockchains, including Ethereum, BNB Chain, Arbitrum, and Optimism. The company has developed an enhanced application programming interface (API) platform aimed at developers, streamlining the process of building and executing blockchain queries. By offering a series of user-friendly APIs, BlockVision enables clients to efficiently manage data interactions within the evolving landscape of web 3.0, thereby improving overall user experience.

Alpha Biopharma

Series B in 2021
Alpha Biopharma Inc. is a biopharmaceutical company based in Huangpu, China, focused on the research and development of innovative therapeutics. The company is actively developing AZD3759, a small molecule tyrosine kinase inhibitor aimed at treating patients with non-small cell lung cancer who have epidermal growth factor receptor (EGFR) mutations and central nervous system metastases. Alpha Biopharma collaborates with prominent domestic and international pharmaceutical companies to enhance the reliability of its product development. The company employs a strong scientific consulting and management team to optimize its drug development strategies, emphasizing a comprehensive approach that includes research, market positioning, and intellectual property protection. Additionally, Alpha Biopharma partners with top contract research organizations, contract manufacturing organizations, hospitals, and institutes to ensure efficient and organized program implementation, supported by a robust project management system.

52Toys

Secondary Market in 2020
52Toys is an animation and intellectual property operator based in Beijing that focuses on creating a social platform for toy enthusiasts and collectors. The company leverages internet technology to foster a community where users can connect, share their collections, and engage with others who have similar interests in models, figurines, and toys. This platform not only facilitates interaction among collectors but also enhances the overall experience of collecting through community engagement and shared passions.

APT Medical

Venture Round in 2019
APT Medical Inc. is a high-tech enterprise focused on the research, development, manufacture, and sale of minimally invasive interventional medical devices targeting cardiovascular and cerebrovascular diseases. The company offers a range of products, including electrophysiological catheter delivery systems, radiofrequency ablation and mapping catheters, as well as various vascular intervention products and accessories. APT Medical also provides OEM and ODM services for catheter and metal products. Founded in 2002 and headquartered in Shenzhen, China, the company operates production facilities in Guanlan, Shenzhen, and Xiangxiang, Hunan, and markets its products across Europe, Eastern Europe, Southeast Asia, and other regions worldwide.

OneAPM

Venture Round in 2019
OneAPM is an IT operation and maintenance management software and service provider. Founded in 2008 in Beijing, the company has always been adhering to the corporate mission of “making the operation and maintenance more intelligent” and is committed to providing integrated intelligent operation and maintenance solutions for enterprise users in China.

Anxin Doctor

Series B in 2019
Anxin Doctor is a mobile healthcare platform focused on maternal and pediatric health. It connects patients with obstetricians, gynecologists, and pediatricians through its application, which facilitates access to healthcare advice and clinical appointment bookings. By bridging the gap between patients and healthcare professionals, Anxin Doctor aims to enhance health outcomes for mothers and children, ensuring timely and efficient medical care.

52Toys

Series A in 2019
52Toys is an animation and intellectual property operator based in Beijing that focuses on creating a social platform for toy enthusiasts and collectors. The company leverages internet technology to foster a community where users can connect, share their collections, and engage with others who have similar interests in models, figurines, and toys. This platform not only facilitates interaction among collectors but also enhances the overall experience of collecting through community engagement and shared passions.

APT Medical

Series C in 2018
APT Medical Inc. is a high-tech enterprise focused on the research, development, manufacture, and sale of minimally invasive interventional medical devices targeting cardiovascular and cerebrovascular diseases. The company offers a range of products, including electrophysiological catheter delivery systems, radiofrequency ablation and mapping catheters, as well as various vascular intervention products and accessories. APT Medical also provides OEM and ODM services for catheter and metal products. Founded in 2002 and headquartered in Shenzhen, China, the company operates production facilities in Guanlan, Shenzhen, and Xiangxiang, Hunan, and markets its products across Europe, Eastern Europe, Southeast Asia, and other regions worldwide.

APT Medical

Series B in 2018
APT Medical Inc. is a high-tech enterprise focused on the research, development, manufacture, and sale of minimally invasive interventional medical devices targeting cardiovascular and cerebrovascular diseases. The company offers a range of products, including electrophysiological catheter delivery systems, radiofrequency ablation and mapping catheters, as well as various vascular intervention products and accessories. APT Medical also provides OEM and ODM services for catheter and metal products. Founded in 2002 and headquartered in Shenzhen, China, the company operates production facilities in Guanlan, Shenzhen, and Xiangxiang, Hunan, and markets its products across Europe, Eastern Europe, Southeast Asia, and other regions worldwide.

Alpha Biopharma

Series A in 2018
Alpha Biopharma Inc. is a biopharmaceutical company based in Huangpu, China, focused on the research and development of innovative therapeutics. The company is actively developing AZD3759, a small molecule tyrosine kinase inhibitor aimed at treating patients with non-small cell lung cancer who have epidermal growth factor receptor (EGFR) mutations and central nervous system metastases. Alpha Biopharma collaborates with prominent domestic and international pharmaceutical companies to enhance the reliability of its product development. The company employs a strong scientific consulting and management team to optimize its drug development strategies, emphasizing a comprehensive approach that includes research, market positioning, and intellectual property protection. Additionally, Alpha Biopharma partners with top contract research organizations, contract manufacturing organizations, hospitals, and institutes to ensure efficient and organized program implementation, supported by a robust project management system.

IDsManager

Series A in 2018
IDsManager is a cloud identity service platform provided by Kyushu Yunteng. Based on the traditional account, authentication, authorization, and auditing 4A, they add our unique application store to form a 5A platform that can provide a unified portal for enterprise users and developers. Rapid development and application integration can be based on this platform.

52Toys

Series A in 2018
52Toys is an animation and intellectual property operator based in Beijing that focuses on creating a social platform for toy enthusiasts and collectors. The company leverages internet technology to foster a community where users can connect, share their collections, and engage with others who have similar interests in models, figurines, and toys. This platform not only facilitates interaction among collectors but also enhances the overall experience of collecting through community engagement and shared passions.

Anxin Doctor

Series B in 2017
Anxin Doctor is a mobile healthcare platform focused on maternal and pediatric health. It connects patients with obstetricians, gynecologists, and pediatricians through its application, which facilitates access to healthcare advice and clinical appointment bookings. By bridging the gap between patients and healthcare professionals, Anxin Doctor aims to enhance health outcomes for mothers and children, ensuring timely and efficient medical care.

APT Medical

Series A in 2016
APT Medical Inc. is a high-tech enterprise focused on the research, development, manufacture, and sale of minimally invasive interventional medical devices targeting cardiovascular and cerebrovascular diseases. The company offers a range of products, including electrophysiological catheter delivery systems, radiofrequency ablation and mapping catheters, as well as various vascular intervention products and accessories. APT Medical also provides OEM and ODM services for catheter and metal products. Founded in 2002 and headquartered in Shenzhen, China, the company operates production facilities in Guanlan, Shenzhen, and Xiangxiang, Hunan, and markets its products across Europe, Eastern Europe, Southeast Asia, and other regions worldwide.

OneAPM

Series D in 2016
OneAPM is an IT operation and maintenance management software and service provider. Founded in 2008 in Beijing, the company has always been adhering to the corporate mission of “making the operation and maintenance more intelligent” and is committed to providing integrated intelligent operation and maintenance solutions for enterprise users in China.

OneAPM

Series C in 2015
OneAPM is an IT operation and maintenance management software and service provider. Founded in 2008 in Beijing, the company has always been adhering to the corporate mission of “making the operation and maintenance more intelligent” and is committed to providing integrated intelligent operation and maintenance solutions for enterprise users in China.

APUS

Series B in 2015
APUS is a Chinese mobile internet technology company established in June 2014, specializing in an enhanced user system for Android smartphones. Its platform provides users with fast and convenient internet access and supports over 25 international languages. By 2017, APUS had attracted more than 1.2 billion users across over 200 countries and regions, with a significant presence in countries along the Belt and Road Initiative. The company's offerings include the APUS System, APUS AI, and APUS Cloud, aimed at enhancing the mobile experience for users. Recognized as one of the world's youngest unicorns in 2015, APUS has been a prominent player in promoting Chinese digital influence globally, focusing on expanding its presence in international markets.

APT Medical

Series A in 2014
APT Medical Inc. is a high-tech enterprise focused on the research, development, manufacture, and sale of minimally invasive interventional medical devices targeting cardiovascular and cerebrovascular diseases. The company offers a range of products, including electrophysiological catheter delivery systems, radiofrequency ablation and mapping catheters, as well as various vascular intervention products and accessories. APT Medical also provides OEM and ODM services for catheter and metal products. Founded in 2002 and headquartered in Shenzhen, China, the company operates production facilities in Guanlan, Shenzhen, and Xiangxiang, Hunan, and markets its products across Europe, Eastern Europe, Southeast Asia, and other regions worldwide.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.